A Phase 2, Open-Label, Sequential Design Study to Evaluate the Drug-drug Interaction between TAK-438 and Low-dose Aspirin or NSAIDs (Loxoprofen Sodium, Diclofenac Sodium or Meloxicam) in Healthy Male Subjects

Trial Profile

A Phase 2, Open-Label, Sequential Design Study to Evaluate the Drug-drug Interaction between TAK-438 and Low-dose Aspirin or NSAIDs (Loxoprofen Sodium, Diclofenac Sodium or Meloxicam) in Healthy Male Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2017

At a glance

  • Drugs Vonoprazan (Primary) ; Aspirin; Diclofenac; Loxoprofen; Meloxicam
  • Indications Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis
  • Focus Pharmacokinetics
  • Sponsors Takeda Pharma
  • Most Recent Events

    • 31 Aug 2016 Results published in the Clinical Drug Investigation
    • 16 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top